HAEMOPHILIA B
Clinical trials for HAEMOPHILIA B explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA B trials appear
Sign up with your email to follow new studies for HAEMOPHILIA B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Japanese hemophilia patients monitored on alhemo in new safety study
Knowledge-focused ENROLLING_BY_INVITATIONThis study tracks the safety and effectiveness of the drug Alhemo (concizumab) in 23 people with hemophilia A or B in Japan. Participants receive the drug as part of their normal care, and researchers will monitor side effects for about 2 years. The goal is to see how well Alhemo…
Matched conditions: HAEMOPHILIA B
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Researchers track real-world safety of haemophilia b drug over nearly a decade
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 60 males with haemophilia B who are already using the drug Refixia (nonacog beta pegol) to prevent bleeding. Researchers will collect information on side effects, bleeding episodes, and quality of life over 4 to 9 years. No new treatment is given—participants c…
Matched conditions: HAEMOPHILIA B
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC